Suppr超能文献

两种模拟临时制剂的药物含量、稳定性分析和药剂师意见的定性评估。

A Drug Content, Stability Analysis, and Qualitative Assessment of Pharmacists' Opinions of Two Exemplar Extemporaneous Formulations.

机构信息

School of Pharmacy, Medical Biology Centre, Queens University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.

出版信息

Molecules. 2020 Jul 6;25(13):3078. doi: 10.3390/molecules25133078.

Abstract

Despite a decline in the number of active pharmaceutical ingredients prepared extemporaneously using proprietary products, there remains a need for such products in the community (for example, liquid medicines for paediatrics which may be otherwise commercially unavailable). A lack of experience and quality assurance systems may have diminished pharmacist's confidence in the extemporaneous preparation process; therefore, pharmacists were asked to prepare two proprietary products, omeprazole and amlodipine. The resulting products were characterised in terms of variability in drug quantity, stability, particle size and antimicrobial properties. Furthermore, a self-administered questionnaire was used to assess 10 pharmacists' opinions on the perceived complexity of the extemporaneous compounding process and their overall confidence in the final extemporaneously compounded products. Drug content studies revealed that 88.5% and 98.0% of the desired drug content was obtained for omeprazole and amlodipine, respectively. Antimicrobial properties were maintained for both drugs, however variability in particle size, particularly for amlodipine, was evident between formulations. While pharmacists who partook in the study had some or high confidence in the final products, they reported difficulty formulating the suspensions. Findings from this study provide insight into pharmacists' views on two extemporaneously prepared products and highlight the variability obtained in preparations prepared by different pharmacists.

摘要

尽管使用专有产品制备的现配药物的活性药物成分数量有所减少,但社区仍需要此类产品(例如,儿科用的液体药物,否则可能无法在商业上获得)。缺乏经验和质量保证体系可能削弱了药剂师对现配制备过程的信心;因此,要求药剂师制备两种专有产品,奥美拉唑和氨氯地平。根据药物数量、稳定性、粒径和抗菌性能的变化来描述所得产品的特征。此外,还使用了一份自我管理的问卷来评估 10 名药剂师对现配化合物制备过程的复杂性的看法,以及他们对最终现配化合物产品的整体信心。药物含量研究表明,奥美拉唑和氨氯地平的目标药物含量分别为 88.5%和 98.0%。两种药物的抗菌性能均得到保持,但是药物粒径的变化,特别是氨氯地平的粒径变化,在不同配方之间是明显的。虽然参与研究的药剂师对最终产品有一定程度或高度的信心,但他们报告说在配制混悬剂时遇到了困难。这项研究的结果提供了药剂师对两种现配药物的看法,并突出了不同药剂师制备的制剂中获得的可变性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验